P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift? | Bentham Science Publishers

2000

Volume 22, Issue 1

ISSN: 1570-1611
E-ISSN: 1875-6212

s P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?
By Felice Gragnano, Antonio Capolongo and Paolo Calabrò
Source: Current Vascular Pharmacology, Volume 22, Issue 1, Jan 2024, p. 1 - 4
DOI: https://doi.org/10.2174/0115701611269735231106110250
- Available online: 01 Jan 2024

Previous Article
Table of Contents
Next Article

Preview this article:

There is no abstract available.

© Bentham Science Publishers

Article metrics loading...

/content/journals/cvp/10.2174/0115701611269735231106110250

2024-01-01

2025-06-19

From This Site

/content/journals/cvp/10.2174/0115701611269735231106110250

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

/content/journals/cvp/10.2174/0115701611269735231106110250

Article Type: Editorial

Keyword(s): Aspirin; coronary artery disease; DAPT; monotherapy; P2Y12 inhibitor; PCI

Most Cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test